Endogenous cardioprotective strategies

Abhiram Prasad, Bernard John Gersh

Research output: Chapter in Book/Report/Conference proceedingChapter


The field of cardioprotection to reduce reperfusion injury has been characterized by a plethora of experimental studies with multiple pharmacological agents that have shown great promise in the laboratory, but have lacked clinical efficacy. This has led to diminishing enthusiasm for the translation of cardioprotection into clinical practice. In contrast, the field of endogenous cardiac protection is particularly appealing given that early clinical studies have documented feasibility and efficacy. Strategies for endogenous cardioprotection include ischemic preconditioning, ischemic postconditioning, and remote ischemic conditioning. However, the clinical trials performed to date have been small, used surrogate endpoints, and had strict inclusion and exclusion criteria. Larger trials are needed that will allow assessment of the applicability to a wider patient population with prior infarcts, prior revascularization, reduced ejection fraction, history of congestive heart failure, use of multiple pharmacological agents, and presence of multiple coexisting diseases. Moreover, understanding the mechanisms for the apparent benefit may lead to the development of new drugs and molecules that could target the fundamental processes of ischemia-reperfusion injury.

Original languageEnglish (US)
Title of host publicationManagement of Myocardial Reperfusion Injury
PublisherSpringer-Verlag London Ltd
Number of pages22
ISBN (Electronic)9781849960199
ISBN (Print)1849960186, 9781849960182
StatePublished - Nov 1 2012


  • Postconditioning
  • Preconditioning
  • Reperfusion injury

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Endogenous cardioprotective strategies'. Together they form a unique fingerprint.

Cite this